Strumento inattivo

Azioni Algeta ASA Xetra

Azioni

Prezzo di chiusura Xetra Altri mercati azionari
- ^EUR	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Actavis : M&A frenzy in healthcare sector	06/05/14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24/03/14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24/02/14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-1,65%	104 Mrd
REGENERON PHARMACEUTICALS, INC.	+6,75%	97,47 Mrd
ARGENX SE	+5,71%	22,25 Mrd
BIONTECH SE	-12,60%	21,68 Mrd
GENMAB A/S	-9,70%	18,2 Mrd
WUXI APPTEC CO., LTD.	-39,98%	17,02 Mrd
BEIGENE, LTD.	-10,17%	16,36 Mrd
NEUROCRINE BIOSCIENCES, INC.	+6,12%	14,39 Mrd
SAREPTA THERAPEUTICS, INC.	+35,47%	12,37 Mrd